Ingevity Q1 net sales $258M (+4%), adj. EPS $1.15 beats $1.01; reaffirms guidance

Ingevity Corp

2026-Q1 EPS reported $1.66 revenue$258,000,000

Net sales $258.0M (+4% YoY); GAAP net income $23.4M ($0.65 diluted EPS) vs $29.1M ($0.79) prior year.
Adjusted earnings from cont. ops $41.4M ($1.15 diluted EPS) vs $37.0M ($1.01) in prior year.
Adjusted EBITDA from cont. ops $91.5M, flat YoY; margin 35.5% vs 36.8%.
Completed sale of N. Charleston refinery & Performance Chemicals Industrial Specialties for ~$93M on Jan 1, 2026; Road Markings sale for ~$65M on Apr 15.
Reaffirms full year guidance, adjusted for sale of Road Markings.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Ingevity Corp updated its full year guidance (reaffirmed).

Period: full year
Guidance: reaffirmed
Result: guidance update

Exact text from the filing

Reaffirms full year guidance, adjusted for sale of Road Markings

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Ingevity Corp reported three months ended March 31, 2026 results: revenue $258.0 million, net income $23.4 million, EPS $0.65.

Period: three months ended March 31, 2026
Revenue: $258.0 million
Net income: $23.4 million
EPS: $0.65
Result: preliminary results

Exact text from the filing

Ingevity reports first quarter 2026 financial results First Quarter 2026 Results & Recent Highlights: • Net sales of $258.0 million increased 4% from prior year • Net income from continuing operations of $23.4 million and $0.65 per diluted share compared to $29.1 million and $0.79 in the prior year

View on SEC.gov

Browse all earnings releases →

Ingevity Corp filing history →

Source: SEC EDGAR

accession 0001653477-26-000031

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.